How does sulbactam treat pneumonia?

What is sulbactam?

Sulbactam is an antibiotic used to treat various bacterial infections, including pneumonia. It belongs to the class of beta-lactamase inhibitors, which work by inhibiting the activity of bacteria-resistant enzymes called beta-lactamases. This allows other antibiotics to effectively target and kill bacteria. [1]

How does sulbactam work against pneumonia?

Sulbactam, often in combination with other antibiotics like ampicillin, targets the bacteria responsible for community-acquired pneumonia (CAP) such as Streptococcus pneumoniae and Haemophilus influenzae. By inhibiting beta-lactamases, sulbactam enhances the activity of the paired antibiotic, promoting a synergistic therapeutic effect against the bacterial infection. [2]

What benefits does sulbactam offer in treating pneumonia?

Studies have shown that the combination of sulbactam and ampicillin can be effective in treating CAP, particularly in patients who are resistant to other antibiotics. [3] Sulbactam also demonstrates a favorable safety profile, with minimal side effects reported.

When is sulbactam used in pneumonia treatment?

Sulbactam is typically prescribed for the treatment of CAP, particularly in cases where other antibiotics have failed. It may be administered orally or intravenously, depending on the severity and severity of the infection.

Patent and availability

The patent for sulbactam expired in 2018, allowing for the development of generic versions and biosimilars. [4]

Please refer to the sources below for further information.

Sources:
[1] - https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4421110/
[2] - https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4491412/
[3] - https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4444110/
[4] - https://www.drugpatentwatch.com/drug/sulbactam/